The landscape of dementia prognosis has evolved significantly with the advent of subtle biomarkers, which include amyloid PET scans, tau imaging, and blood-based mostly tests which will detect Alzheimer's pathology several years prior to symptoms emerge. While these technological advancements symbolize remarkable progress in understanding neurodegenerative disorders, they've not dimin... https://robertr652qbl2.blogitright.com/profile